111 related articles for article (PubMed ID: 1724353)
1. sCD14 prevents endotoxin inducible oxidative burst response of human monocytes.
Schütt C; Schilling T; Krüger C
Allerg Immunol (Leipz); 1991; 37(3-4):159-64. PubMed ID: 1724353
[TBL] [Abstract][Full Text] [Related]
2. Endotoxin-neutralizing capacity of soluble CD14 is a highly conserved specific function.
Grunwald U; Krüger C; Schütt C
Circ Shock; 1993 Mar; 39(3):220-5. PubMed ID: 7680967
[TBL] [Abstract][Full Text] [Related]
3. Endotoxin-neutralizing capacity of soluble CD14.
Schütt C; Schilling T; Grunwald U; Schönfeld W; Krüger C
Res Immunol; 1992 Jan; 143(1):71-8. PubMed ID: 1373513
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the endotoxin receptor (CD14) in septic patients.
Birkenmaier C; Hong YS; Horn JK
J Trauma; 1992 Apr; 32(4):473-8; discussion 478-9. PubMed ID: 1373777
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells.
Golenbock DT; Bach RR; Lichenstein H; Juan TS; Tadavarthy A; Moldow CF
J Lab Clin Med; 1995 May; 125(5):662-71. PubMed ID: 7537790
[TBL] [Abstract][Full Text] [Related]
6. Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14.
Labeta MO; Durieux JJ; Fernandez N; Herrmann R; Ferrara P
Eur J Immunol; 1993 Sep; 23(9):2144-51. PubMed ID: 7690322
[TBL] [Abstract][Full Text] [Related]
7. The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human monocytes.
Durieux JJ; Vita N; Popescu O; Guette F; Calzada-Wack J; Munker R; Schmidt RE; Lupker J; Ferrara P; Ziegler-Heitbrock HW
Eur J Immunol; 1994 Sep; 24(9):2006-12. PubMed ID: 7522157
[TBL] [Abstract][Full Text] [Related]
8. [Endotoxin neutralization by soluble CD14 in vitro].
Schütt C; Schilling T; Krüger C
Immun Infekt; 1992 Jul; 20(3):87-9. PubMed ID: 1379977
[No Abstract] [Full Text] [Related]
9. Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants.
Bufler P; Stiegler G; Schuchmann M; Hess S; Krüger C; Stelter F; Eckerskorn C; Schütt C; Engelmann H
Eur J Immunol; 1995 Feb; 25(2):604-10. PubMed ID: 7533093
[TBL] [Abstract][Full Text] [Related]
10. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood.
Haziot A; Rong GW; Bazil V; Silver J; Goyert SM
J Immunol; 1994 Jun; 152(12):5868-76. PubMed ID: 7515917
[TBL] [Abstract][Full Text] [Related]
11. Binding sites for endotoxins (lipopolysaccharides) on human monocytes.
Couturier C; Haeffner-Cavaillon N; Caroff M; Kazatchkine MD
J Immunol; 1991 Sep; 147(6):1899-904. PubMed ID: 1716284
[TBL] [Abstract][Full Text] [Related]
12. Modalities of endotoxin binding to CD14.
Schütt C; Schilling T; Stelter F; Fürll B; Krüger C; Witt S; Jack R; Grunwald U
Prog Clin Biol Res; 1995; 392():339-48. PubMed ID: 8524939
[No Abstract] [Full Text] [Related]
13. Expression and release of the monocyte lipopolysaccharide receptor antigen CD14 are suppressed by glucocorticoids in vivo and in vitro.
Nockher WA; Scherberich JE
J Immunol; 1997 Feb; 158(3):1345-52. PubMed ID: 9013978
[TBL] [Abstract][Full Text] [Related]
14. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide.
Haziot A; Rong GW; Silver J; Goyert SM
J Immunol; 1993 Aug; 151(3):1500-7. PubMed ID: 7687634
[TBL] [Abstract][Full Text] [Related]
15. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein.
Tobias PS; Soldau K; Kline L; Lee JD; Kato K; Martin TP; Ulevitch RJ
J Immunol; 1993 Apr; 150(7):3011-21. PubMed ID: 7681085
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide.
Camussi G; Mariano F; Biancone L; De Martino A; Bussolati B; Montrucchio G; Tobias PS
J Immunol; 1995 Jul; 155(1):316-24. PubMed ID: 7541418
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein.
Leeuwenberg JF; Dentener MA; Buurman WA
J Immunol; 1994 May; 152(10):5070-6. PubMed ID: 7513728
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide.
Haziot A; Tsuberi BZ; Goyert SM
J Immunol; 1993 Jun; 150(12):5556-65. PubMed ID: 7685797
[TBL] [Abstract][Full Text] [Related]
19. Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteins.
Kitchens RL; Thompson PA
J Endotoxin Res; 2003; 9(2):113-8. PubMed ID: 12803885
[TBL] [Abstract][Full Text] [Related]
20. Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages. Role of LPS receptors.
Gessani S; Testa U; Varano B; Di Marzio P; Borghi P; Conti L; Barberi T; Tritarelli E; Martucci R; Seripa D
J Immunol; 1993 Oct; 151(7):3758-66. PubMed ID: 7690813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
